No abstract available
Keywords:
EGFR; Lung cancer; Osimertinib; Risk; Thrombosis.
MeSH terms
-
Acrylamides / adverse effects
-
Aniline Compounds / adverse effects
-
Humans
-
Lung Neoplasms* / complications
-
Lung Neoplasms* / drug therapy
-
Mutation
-
Protein Kinase Inhibitors
-
Venous Thromboembolism* / drug therapy
Substances
-
Acrylamides
-
Aniline Compounds
-
Protein Kinase Inhibitors
-
osimertinib